This is a summary of the European public assessment report (EPAR) for Verkazia. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Verkazia. For practical information about using Verkazia, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents.
Therapeutic Area (MeSH)
ATC Code
S01XA18
ATC Item
ciclosporin
Pharmacotherapeutic Group
Ophthalmologicals
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| ciclosporin | N/A | 环孢素 |
EMA Name
Verkazia
Medicine Name
Verkazia
Aliases
N/A